Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer - Tie, J; Wang, Y; Tomasetti, C; Li, L; Springer, S; Kinde, I (Sci Transl Med, 2016)
(346):